Montelukast Torrent Pharma (Uk) (Montelukast Sodium)

Montelukast, the active ingredient in Montelukast Torrent Pharma (Uk), is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma, exercise‑induced bronchoconstriction, and allergic rhinitis in adults and children as directed by a healthcare professional.

GNH USA supplies Montelukast Torrent Pharma (Uk) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with full regulatory compliance and quality assurance across Europe, Asia and the Americas, and adheres to stringent GMP standards.

Montelukast, a leukotriene receptor antagonist, is used to treat conditions mediated by cysteinyl leukotrienes. - Asthma: improves control of persistent asthma and reduces the frequency of exacerbations. - Exercise‑induced bronchoconstriction: prevents narrowing of the airways during or after physical activity. - Allergic rhinitis: alleviates nasal congestion, sneezing and itching caused by seasonal allergens.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Abdominal pain: discomfort in the stomach area, usually transient. - Cough: occasional irritation of the throat. - Nausea: feeling of queasiness, may be mild. - Diarrhea: loose stools occurring sporadically. - Fatigue: general sense of tiredness.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis requiring immediate medical attention. - Neuropsychiatric events: mood changes, depression, or suicidal thoughts. - Hepatic enzyme elevation: abnormal liver function tests. - Stevens‑Johnson syndrome: severe skin reactions. - Eosinophilic granulomatosis with polyangiitis: rare vasculitic disorder. - Blood dyscrasias: uncommon blood cell abnormalities.

Before prescribing Montelukast, clinicians should consider several safety aspects. - Assess asthma control before initiating: ensure the patient is on appropriate inhaled therapy. - Monitor for neuropsychiatric events: watch for mood changes or depression. - Use with caution in hepatic impairment: adjust if needed. - Avoid in patients with known hypersensitivity to montelukast or excipients. - Pregnancy and lactation: discuss risk/benefit with the prescriber. - Store at room temperature: keep in the original container, protect from moisture and heat.

Montelukast may interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Ritonavir: may increase montelukast plasma concentrations. - Phenobarbital: may reduce montelukast effectiveness. - Carbamazepine: may lower montelukast exposure.

Moderate Interactions (Monitor Closely): - Fluconazole: may modestly increase montelukast levels. - Warfarin: monitor INR as montelukast can affect metabolism. - Theophylline: observe for additive bronchial effects.